Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

Condition:   Type1 Diabetes Interventions:   Device: HCL;   Drug: verapamil 120mg tablet;   Device: non-HCL;   Drug: placebo Sponsors:   Jaeb Center for Health Research;   University of Minnesota;   Medtronic;   Tandem Diabetes Care, Inc.;   DexCom, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials